Status:
COMPLETED
GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study
Lead Sponsor:
W.L.Gore & Associates
Conditions:
Vascular Stent-Graft Stenosis
Eligibility:
All Genders
Brief Summary
This study will confirm the efficacy and safety in the clinical setting after the launch of the GORE® VIABAHN® stent graft (hereafter referred to as "Viabahn") for the treatment of patients with steno...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Participants who developed stenosis or occlusion at the venous anastomosis of synthetic arteriovenous access graft
- Participants who was used to repair vascular access circuits for purposes other than treatment of stenosis or occlusion at the venous anastomosis of synthetic arteriovenous access graft
Exclusion
Key Trial Info
Start Date :
July 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 6 2023
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT04429243
Start Date
July 2 2020
End Date
October 6 2023
Last Update
November 29 2024
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaikoukai Central Clinic
Nagoya, Aichi-ken, Japan, 454-0933
2
Nagoya Vascular Access Clinic
Nagoya, Aichi-ken, Japan, 464-0850
3
Matsuyama Red Cross Hospital
Matsuyama, Ehime, Japan, 790-8524
4
Kansai Rosai Hospital
Amagasaki, Hyōgo, Japan, 660-8511